How to trick the body's metabolismNew research suggests a way to maintain calorie burning during weight loss despite reduced calorie intake.
5 new weight-loss drugs to watch in the fight for the next OzempicGLP-1 medications revolutionize healthcare, but new formulations promise even greater effectiveness and convenience for weight loss and diabetes management.
All About Ozempic and the Next Generation of Obesity DrugsOzempic belongs to a class of GLP-1 receptor agonists, aiding weight loss and diabetes treatment with similar drugs like Wegovy, Mounjaro, and Zepbound.
How to trick the body's metabolismNew research suggests a way to maintain calorie burning during weight loss despite reduced calorie intake.
5 new weight-loss drugs to watch in the fight for the next OzempicGLP-1 medications revolutionize healthcare, but new formulations promise even greater effectiveness and convenience for weight loss and diabetes management.
All About Ozempic and the Next Generation of Obesity DrugsOzempic belongs to a class of GLP-1 receptor agonists, aiding weight loss and diabetes treatment with similar drugs like Wegovy, Mounjaro, and Zepbound.
Ozempic Cuts Risk of Kidney Disease Death in People with DiabetesOzempic/Wegovy (semaglutide) reduces kidney failure risk by 24% for type 2 diabetes patients with chronic kidney disease.
Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030Ozempic, originally a diabetes treatment, has become a major weight loss drug, generating $14 billion in 2023 sales for Novo Nordisk.
On a Mission to Heal Gila MonstersOzempic's success is tied to a hormone from the Gila monster, showcasing the unexpected links between wildlife and modern medicine.
How Ozempic Is Changing Diabetes TreatmentUsing drugs like Ozempic can help patients with Type 2 diabetes reduce their reliance on insulin, providing a sense of freedom and potentially better control over glucose levels.
Ozempic Cuts Risk of Kidney Disease Death in People with DiabetesOzempic/Wegovy (semaglutide) reduces kidney failure risk by 24% for type 2 diabetes patients with chronic kidney disease.
Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030Ozempic, originally a diabetes treatment, has become a major weight loss drug, generating $14 billion in 2023 sales for Novo Nordisk.
On a Mission to Heal Gila MonstersOzempic's success is tied to a hormone from the Gila monster, showcasing the unexpected links between wildlife and modern medicine.
How Ozempic Is Changing Diabetes TreatmentUsing drugs like Ozempic can help patients with Type 2 diabetes reduce their reliance on insulin, providing a sense of freedom and potentially better control over glucose levels.
Researching lizard poison led to Ozempic. It's the kind of breakthrough that science funding cuts could endThe discovery of GLP-1 drugs showcases how foundational research can lead to significant medical innovations for diabetes treatment.
Ozempic may help battle drug and alcohol addictionWeight-loss drugs Ozempic and Mounjaro may help reduce substance abuse cravings and binging, showing protective effects on overdose and binge drinking rates.
Stem Cell Treatment Worked on One Patient's Type 1 DiabetesStem cell therapy shows promising results in reversing type 1 diabetes, leading to sustained insulin independence and improved glycemic control.
FTC sues insulin middlemen, saying they pocket billions while patients face high costsThe FTC is targeting pharmacy benefit managers to address high insulin costs, which have shot up by 600% over two decades, impacting diabetic patients.
Weight-loss drugs like Wegovy may help stave off some cancersGLP-1 agonist drugs like Ozempic and Wegovy show promise in preventing common cancers associated with obesity and excess weight.
Diabetes drugs test a new side effect: slowing down symptoms of Parkinson'sGLP-1 receptor agonists have potential benefits beyond just treating diabetes and obesity, potentially impacting diseases like Alzheimer's and Parkinson's positively.